CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines I...
Saved in:
Published in | European Journal of Immunology Vol. 34; no. 7; pp. 1992 - 2000 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY‐VCH Verlag
01.07.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines IL‐8/CXCL8 and GCP‐2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL‐8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double‐stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL‐8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP‐2, but not ENA‐78/CXCL5, nor IL‐8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL‐8 than GCP‐2. The selective GCP‐2 staining of endothelial cells at sites of ulcerations suggests that GCP‐2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA‐78) and functionally (IL‐8) related ELR+ CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy. |
---|---|
AbstractList | Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro-inflammatory cytokines and chemokines. The intestinal expression of the CXCR1-binding chemokines IL-8/CXCL8 and GCP-2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL-8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double-stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL-8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP-2, but not ENA-78/CXCL5, nor IL-8, were highly expressed by endothelial cells in inflamed intestinal tissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL-8 than GCP-2. The selective GCP-2 staining of endothelial cells at sites of ulcerations suggests that GCP-2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA-78) and functionally (IL-8) related ELR(+) CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy. Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines IL‐8/CXCL8 and GCP‐2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL‐8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double‐stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL‐8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP‐2, but not ENA‐78/CXCL5, nor IL‐8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL‐8 than GCP‐2. The selective GCP‐2 staining of endothelial cells at sites of ulcerations suggests that GCP‐2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA‐78) and functionally (IL‐8) related ELR+ CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy. Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro-inflammatory cytokines and chemokines. The intestinal expression of the CXCR1-binding chemokines IL-8/CXCL8 and GCP-2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL-8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double-stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL-8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP-2, but not ENA-78/CXCL5, nor IL-8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL-8 than GCP-2. The selective GCP-2 staining of endothelial cells at sites of ulcerations suggests that GCP-2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA-78) and functionally (IL-8) related ELR super(+) CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy. Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines IL‐8/CXCL8 and GCP‐2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL‐8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double‐stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL‐8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP‐2, but not ENA‐78/CXCL5, nor IL‐8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL‐8 than GCP‐2. The selective GCP‐2 staining of endothelial cells at sites of ulcerations suggests that GCP‐2, despite its low production capacity in vitro , plays a role in IBD that is different from that of structurally (ENA‐78) and functionally (IL‐8) related ELR + CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy. |
Author | Geboes, Karel Struyf, Sofie Van Damme, Jo Van Assche, Gert Proost, Paul Joossens, Sofie Rutgeerts, Paul Gijsbers, Klara |
Author_xml | – sequence: 1 givenname: Klara surname: Gijsbers fullname: Gijsbers, Klara – sequence: 2 givenname: Gert surname: Van Assche fullname: Van Assche, Gert – sequence: 3 givenname: Sofie surname: Joossens fullname: Joossens, Sofie – sequence: 4 givenname: Sofie surname: Struyf fullname: Struyf, Sofie – sequence: 5 givenname: Paul surname: Proost fullname: Proost, Paul – sequence: 6 givenname: Paul surname: Rutgeerts fullname: Rutgeerts, Paul – sequence: 7 givenname: Karel surname: Geboes fullname: Geboes, Karel – sequence: 8 givenname: Jo surname: Van Damme fullname: Van Damme, Jo email: jozef.vandamme@rega.kuleuven.ac.be |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15214047$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksFu1DAQhi1URLeFI1fkE5zS2onjxNxQVMqilUAIJG6RnYxbt4692AlLbn2EvhavwZPgZdtFQgIkS5al7_88Y88ROnDeAUJPKTmhhOSncGVOckKKnNWkeoAWtMxpxiijB2hBCGVZLmpyiI5ivCKECF6KR-hwCzHCqgX63nxuPtAfN7fKuN64C9xdwuCvjYOIjUtLWzkMcvRhxspvwOLeRJAR4kvc-41LyQAXk5Uj9Hi5Ssf6NClXNV4H30_daLzDasYWpmvfzeNO2wR_6V7EexeWrscRLCT8K-Dz5n3y5L88HMO3dYAYt559Qeku45JrNE5aPJoYJ3iMHmppIzy524_Rp9dnH5s32erd-bJ5tco6VrAqY4UUNJdVWZdM81JXShS6K2tV85JQAZJr0UmZa6I0k1woDkoIUind1TVoVRyj5ztvavDLlGpoBxM7sFY68FNsOeeMc0r_C1LBClESlsBnd-CkUmvtOphBhrm9_6UEFDugCz7GALrtzCi3TzsGaWxLSbudhTbNQrufhZTK_kjtxX_hqx2_MRbmf8Pt2dvl7-RPCKvMPw |
CitedBy_id | crossref_primary_10_1073_pnas_1820130116 crossref_primary_10_3389_fimmu_2014_00491 crossref_primary_10_1007_s00384_006_0135_4 crossref_primary_10_1016_j_bcp_2017_02_021 crossref_primary_10_1016_j_fct_2017_12_028 crossref_primary_10_1007_s12272_011_0111_6 crossref_primary_10_1007_s10048_014_0409_x crossref_primary_10_3390_nu9020165 crossref_primary_10_1038_s41598_019_51328_0 crossref_primary_10_1111_j_1365_2036_2006_03016_x crossref_primary_10_1902_jop_2008_080139 crossref_primary_10_1007_s10238_023_01152_8 crossref_primary_10_1016_j_lfs_2007_09_024 crossref_primary_10_3390_biomedicines11123229 crossref_primary_10_1111_j_1600_0765_2008_01134_x crossref_primary_10_1016_j_ymeth_2011_09_009 crossref_primary_10_1016_j_intimp_2024_113408 crossref_primary_10_3390_ijms18081692 crossref_primary_10_1097_MPG_0b013e3182318d13 crossref_primary_10_4137_CGast_S20612 crossref_primary_10_1016_j_vetimm_2010_05_001 crossref_primary_10_1016_j_arcmed_2020_08_005 crossref_primary_10_1080_00365520802273017 crossref_primary_10_1111_ajt_12942 crossref_primary_10_1002_cam4_1147 crossref_primary_10_1002_JLB_3A0820_207R crossref_primary_10_1016_j_febslet_2005_07_038 crossref_primary_10_1111_j_1751_2980_2008_00336_x crossref_primary_10_1111_j_1600_0897_2008_00620_x crossref_primary_10_4049_jimmunol_0800551 crossref_primary_10_4049_jimmunol_1500148 crossref_primary_10_1016_j_biopha_2018_10_050 crossref_primary_10_1093_ecco_jcc_jjaa236 crossref_primary_10_1111_j_1365_2249_2006_03089_x crossref_primary_10_1093_ibd_izac233 crossref_primary_10_1016_j_anaerobe_2021_102458 crossref_primary_10_1177_0022034509347296 crossref_primary_10_1371_journal_pcbi_1004314 crossref_primary_10_1016_j_febslet_2015_10_029 crossref_primary_10_1016_j_pharmthera_2006_04_002 crossref_primary_10_3177_jnsv_55_442 crossref_primary_10_3389_fgene_2022_950136 crossref_primary_10_3390_jcm12072671 crossref_primary_10_1016_j_bcp_2007_06_034 crossref_primary_10_3389_fmed_2024_1387210 crossref_primary_10_1016_j_cytogfr_2018_10_004 crossref_primary_10_1093_jleuko_qiad097 crossref_primary_10_1073_pnas_1510084112 crossref_primary_10_1016_j_jri_2008_08_003 crossref_primary_10_1016_j_celrep_2021_110057 crossref_primary_10_3389_fcimb_2021_781022 crossref_primary_10_1097_TP_0b013e31818fe7fe crossref_primary_10_1186_s13059_016_1084_z crossref_primary_10_3899_jrheum_161092 |
Cites_doi | 10.4049/jimmunol.150.3.1000 10.1021/bi961999z 10.1002/jlb.59.6.804 10.1016/S0016-5085(98)70476-7 10.4049/jimmunol.140.5.1534 10.1046/j.1365-2567.2002.01309.x 10.1002/eji.1830190706 10.1016/S0167-5699(99)01469-3 10.1046/j.1365-2796.2001.00867.x 10.1016/S0002-9440(10)63022-2 10.1038/35079107 10.1046/j.1432-1327.1998.2550067.x 10.1189/jlb.68.1.1 10.1046/j.1365-2249.2000.01364.x 10.1007/s00428-002-0684-z 10.1016/S0002-9440(10)63564-X 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4 10.1002/path.1245 10.1016/S0002-9440(10)64034-5 10.1016/S0140-6736(02)07499-8 10.1074/jbc.M008072200 10.1023/A:1020583306627 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S 10.1097/01.LAB.0000048719.53282.00 10.1074/jbc.270.45.27348 10.1189/jlb.72.1.9 10.1080/003655201750313397 10.1136/gut.38.2.216 10.1056/NEJM199802123380706 10.1016/S0002-9440(10)62527-8 10.1084/jem.167.2.570 10.1080/003655201750153377 10.1038/35079114 10.1182/blood.V90.3.909 10.1136/gut.47.3.404 10.1007/PL00000223 10.1016/S0140-6736(02)07284-7 10.1056/NEJMra020831 10.1136/gut.38.1.90 10.1002/1521-4141(200112)31:12<3755::AID-IMMU3755>3.0.CO;2-O |
ContentType | Journal Article |
Copyright | Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim |
Copyright_xml | – notice: Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
DOI | 10.1002/eji.200324807 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1521-4141 1365-2567 |
EndPage | 2000 |
ExternalDocumentID | 15214047 10_1002_eji_200324807 EJI200324807 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .HR .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OK1 OVD P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 UPT V2E VH1 W8V W99 WBKPD WHWMO WIB WIH WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXSBR X7M XG1 XPP XV2 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM -~X 29I 2WC 36B 52R 52V 5HH 5LA 7T5 A01 A8Z AAFWJ AAKAS AAMMB ABDBF ABXGK ACGFO ACGOF ACIWK ACMXC ACNCT ACUHS ADBTR ADZCM AEFGJ AEGXH AFEBI AGXDD AIACR AIAGR AIDQK AIDYY AOIJS BAWUL C45 CAG COF D-6 D-7 DIK DRMAN E3Z EAD EAP EAS EBB EBC EBX EMB EMK EPT ESX EX3 FD6 FIJ FUBAC GX1 H94 HZI IH2 IHE K48 KBYEO MRMAN MSMAN MXMAN OBC OBS P2Z P4B Q~Q RPM TR2 TUS V8K WH7 WIJ WOQ WOW WXI YF5 YFH YOC YUY 7X8 |
ID | FETCH-LOGICAL-c4347-43a912a75854f65f7b93fc58b865019ea6f9caa2f0bf4a69b6eb9907bfc88efb3 |
IEDL.DBID | DR2 |
ISSN | 0014-2980 |
IngestDate | Thu Jul 10 23:04:41 EDT 2025 Thu Jul 10 19:02:29 EDT 2025 Wed Feb 19 01:42:07 EST 2025 Tue Jul 01 00:48:27 EDT 2025 Thu Apr 24 23:12:33 EDT 2025 Wed Jan 22 16:20:28 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4347-43a912a75854f65f7b93fc58b865019ea6f9caa2f0bf4a69b6eb9907bfc88efb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 15214047 |
PQID | 19439504 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_66646611 proquest_miscellaneous_19439504 pubmed_primary_15214047 crossref_citationtrail_10_1002_eji_200324807 crossref_primary_10_1002_eji_200324807 wiley_primary_10_1002_eji_200324807_EJI200324807 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2004 |
PublicationDateYYYYMMDD | 2004-07-01 |
PublicationDate_xml | – month: 07 year: 2004 text: July 2004 |
PublicationDecade | 2000 |
PublicationPlace | Weinheim |
PublicationPlace_xml | – name: Weinheim – name: Germany |
PublicationTitle | European Journal of Immunology |
PublicationTitleAlternate | Eur J Immunol |
PublicationYear | 2004 |
Publisher | WILEY‐VCH Verlag |
Publisher_xml | – name: WILEY‐VCH Verlag |
References | 1998; 28 2001; 50 2000; 47 2002; 72 2000; 68 2002; 359 1998; 338 1988; 167 1999; 20 1998; 114 1988; 140 1996; 38 1998; 255 1996; 59 2003; 199 1995; 270 2001; 276 1997; 90 1994; 144 2001; 250 1997; 92 1999; 19 1997; 36 2002; 441 1993; 150 2002; 347 2002; 105 2000; 122 2003; 83 2001; 36 1996; 178 1989; 19 2001; 159 2001; 158 2001; 411 2001; 31 2003; 163 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_6_2 e_1_2_7_19_2 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_15_2 e_1_2_7_1_2 e_1_2_7_14_2 e_1_2_7_40_2 e_1_2_7_13_2 e_1_2_7_41_2 e_1_2_7_12_2 e_1_2_7_42_2 e_1_2_7_11_2 Mazzucchelli L. (e_1_2_7_20_2) 1994; 144 e_1_2_7_10_2 e_1_2_7_26_2 e_1_2_7_27_2 e_1_2_7_29_2 Stahlberg D. (e_1_2_7_28_2) 1997; 92 e_1_2_7_25_2 e_1_2_7_24_2 e_1_2_7_30_2 e_1_2_7_23_2 e_1_2_7_31_2 e_1_2_7_22_2 e_1_2_7_32_2 Van Damme J. (e_1_2_7_16_2) 1988; 140 e_1_2_7_21_2 e_1_2_7_33_2 e_1_2_7_34_2 e_1_2_7_35_2 e_1_2_7_36_2 e_1_2_7_37_2 e_1_2_7_38_2 e_1_2_7_39_2 Proost P. (e_1_2_7_7_2) 1993; 150 |
References_xml | – volume: 347 start-page: 417 year: 2002 end-page: 429 article-title: Inflammatory bowel disease. publication-title: N. Engl. J. Med. – volume: 47 start-page: 404 year: 2000 end-page: 409 article-title: A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. publication-title: Gut – volume: 167 start-page: 570 year: 1988 end-page: 581 article-title: Macrophages secrete a novel heparin‐binding protein with inflammatory and neutrophil chemokinetic properties. publication-title: J. Exp. Med. – volume: 38 start-page: 216 year: 1996 end-page: 222 article-title: Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. publication-title: Gut – volume: 72 start-page: 9 year: 2002 end-page: 18 article-title: Role of CXCL1 in tumorigenesis of melanoma. publication-title: J. Leukoc. Biol. – volume: 140 start-page: 1534 year: 1988 end-page: 1541 article-title: Separation and comparison of two monokines with lymphocyte‐activating factor activity: IL‐1 beta and hybridoma growth factor (HGF). Identification of leukocyte‐derived HGF as IL‐6. publication-title: J. Immunol. – volume: 359 start-page: 62 year: 2002 end-page: 69 article-title: Crohn's disease. publication-title: Lancet – volume: 441 start-page: 500 year: 2002 end-page: 513 article-title: Cytokine/chemokine messenger‐RNA expression profiles in ulcerative colitis and Crohn's disease. publication-title: Virchows Arch. – volume: 68 start-page: 1 year: 2000 end-page: 8 article-title: CXC chemokines in angiogenesis. publication-title: J. Leukoc. Biol. – volume: 158 start-page: 855 year: 2001 end-page: 866 article-title: The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. publication-title: Am. J. Pathol. – volume: 255 start-page: 67 year: 1998 end-page: 73 article-title: Differential usage of the CXC chemokine receptors 1 and 2 by interleukin‐8, granulocyte chemotactic protein‐2 and epithelial‐cell‐derived neutrophil attractant‐78. publication-title: Eur. J. Biochem. – volume: 411 start-page: 603 year: 2001 end-page: 606 article-title: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. publication-title: Nature – volume: 163 start-page: 2065 year: 2003 end-page: 2075 article-title: PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia. publication-title: Am. J. Pathol. – volume: 36 start-page: 2716 year: 1997 end-page: 2723 article-title: Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. publication-title: Biochemistry – volume: 19 start-page: 1189 year: 1989 end-page: 1194 article-title: The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte‐derived interleukin 8. publication-title: Eur. J. Immunol. – volume: 38 start-page: 90 year: 1996 end-page: 98 article-title: Interleukin 8: cells of origin in inflammatory bowel disease. publication-title: Gut – volume: 150 start-page: 1000 year: 1993 end-page: 1010 article-title: Identification of a novel granulocyte chemotactic protein (GCP‐2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP‐10, and IL‐8. publication-title: J. Immunol. – volume: 50 start-page: 491 year: 2001 end-page: 495 article-title: Tissue cytokine and chemokine expression in inflammatory bowel disease. publication-title: Inflamm. Res. – volume: 31 start-page: 3755 year: 2001 end-page: 3762 article-title: Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. publication-title: Eur. J. Immunol. – volume: 199 start-page: 28 year: 2003 end-page: 35 article-title: Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. publication-title: J. Pathol. – volume: 36 start-page: 854 year: 2001 end-page: 864 article-title: Coordinateupregulation of interleukin‐8 and growth‐related gene product‐alpha is present in the colonic mucosa of inflammatory bowel. publication-title: Scand. J. Gastroenterol. – volume: 159 start-page: 1405 year: 2001 end-page: 1414 article-title: Tumor angiogenesis induced by granulocyte chemotactic protein‐2 as a countercurrent principle. publication-title: Am. J. Pathol. – volume: 20 start-page: 254 year: 1999 end-page: 257 article-title: The chemokine system: redundancy for robust outputs. publication-title: Immunol. Today – volume: 92 start-page: 283 year: 1997 end-page: 288 article-title: Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histologial assessment and Tc‐99 m‐HMPAO labeled leukocyte scan. publication-title: Am. J. Gastroenterol. – volume: 338 start-page: 436 year: 1998 end-page: 445 article-title: Chemokines–chemotactic cytokines that mediate inflammation. publication-title: N. Engl. J. Med. – volume: 276 start-page: 4812 year: 2001 end-page: 4818 article-title: Nod2, a Nod1/Apaf‐1 family member that is restricted to monocytes and activates NF‐kappaB. publication-title: J. Biol. Chem. – volume: 114 start-page: 262 year: 1998 end-page: 267 article-title: Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. publication-title: Gastroenterology – volume: 250 start-page: 91 year: 2001 end-page: 104 article-title: Chemokines in pathology and medicine. publication-title: J. Intern. Med. – volume: 122 start-page: 180 year: 2000 end-page: 185 article-title: Enhanced production of IL‐8 in chronic but not in early ileal lesions of Crohn's disease (CD). publication-title: Clin. Exp. Immunol. – volume: 411 start-page: 599 year: 2001 end-page: 603 article-title: Association of NOD2 leucine‐rich repeat variants with susceptibility to Crohn's disease. publication-title: Nature – volume: 28 start-page: 164 year: 1998 end-page: 170 article-title: Granulocyte chemotactic protein 2 acts via both IL‐8 receptors, CXCR1 and CXCR2. publication-title: Eur. J. Immunol. – volume: 19 start-page: 266 year: 1999 end-page: 272 article-title: Chemokines in the inflammatory bowel diseases. publication-title: J. Clin. Immunol. – volume: 90 start-page: 909 year: 1997 end-page: 928 article-title: Chemokines. publication-title: Blood – volume: 36 start-page: 515 year: 2001 end-page: 520 article-title: Increased serum levels of eotaxin in patients with inflammatory bowel disease. publication-title: Scand. J. Gastroenterol. – volume: 59 start-page: 804 year: 1996 end-page: 812 article-title: Enhanced expression and production of monocyte chemoattractant protein‐1 in inflammatory bowel disease mucosa. publication-title: J. Leukoc. Biol. – volume: 144 start-page: 997 year: 1994 end-page: 1007 article-title: Expression of interleukin‐8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. publication-title: Am. J. Pathol. – volume: 359 start-page: 331 year: 2002 end-page: 340 article-title: Ulcerative colitis. publication-title: Lancet – volume: 178 start-page: 201 year: 1996 end-page: 206 article-title: Differential in situ expression of the genes encoding the chemokines MCP‐1 and RANTES in human inflammatory bowel disease. publication-title: J. Pathol. – volume: 159 start-page: 1751 year: 2001 end-page: 1761 article-title: Expression of the T cell chemoattractant chemokine lymphotactin in Crohn's disease. publication-title: Am. J. Pathol. – volume: 83 start-page: 23 year: 2003 end-page: 34 article-title: The CXC chemokine GCP‐2/CXCL6 is predominantly induced in mesenchymal cells byinterleukin‐1beta and is down‐regulated by interferon‐gamma: comparison with interleukin‐8/CXCL8. publication-title: Lab. Invest. – volume: 270 start-page: 27348 year: 1995 end-page: 27357 article-title: The functional role of the ELR motif in CXC chemokine‐mediated angiogenesis. publication-title: J. Biol. Chem. – volume: 105 start-page: 137 year: 2002 end-page: 143 article-title: Role of chemokines and chemokine receptors in the gastrointestinal tract. publication-title: Immunology – volume: 150 start-page: 1000 year: 1993 ident: e_1_2_7_7_2 article-title: Identification of a novel granulocyte chemotactic protein (GCP‐2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP‐10, and IL‐8. publication-title: J. Immunol. doi: 10.4049/jimmunol.150.3.1000 – ident: e_1_2_7_8_2 doi: 10.1021/bi961999z – ident: e_1_2_7_34_2 doi: 10.1002/jlb.59.6.804 – ident: e_1_2_7_41_2 doi: 10.1016/S0016-5085(98)70476-7 – volume: 140 start-page: 1534 year: 1988 ident: e_1_2_7_16_2 article-title: Separation and comparison of two monokines with lymphocyte‐activating factor activity: IL‐1 beta and hybridoma growth factor (HGF). Identification of leukocyte‐derived HGF as IL‐6. publication-title: J. Immunol. doi: 10.4049/jimmunol.140.5.1534 – ident: e_1_2_7_18_2 doi: 10.1046/j.1365-2567.2002.01309.x – ident: e_1_2_7_17_2 doi: 10.1002/eji.1830190706 – ident: e_1_2_7_31_2 doi: 10.1016/S0167-5699(99)01469-3 – ident: e_1_2_7_5_2 doi: 10.1046/j.1365-2796.2001.00867.x – ident: e_1_2_7_24_2 doi: 10.1016/S0002-9440(10)63022-2 – ident: e_1_2_7_35_2 doi: 10.1038/35079107 – ident: e_1_2_7_27_2 doi: 10.1046/j.1432-1327.1998.2550067.x – ident: e_1_2_7_3_2 doi: 10.1189/jlb.68.1.1 – ident: e_1_2_7_29_2 doi: 10.1046/j.1365-2249.2000.01364.x – ident: e_1_2_7_15_2 doi: 10.1007/s00428-002-0684-z – ident: e_1_2_7_40_2 doi: 10.1016/S0002-9440(10)63564-X – ident: e_1_2_7_21_2 doi: 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4 – ident: e_1_2_7_14_2 doi: 10.1002/path.1245 – ident: e_1_2_7_23_2 doi: 10.1016/S0002-9440(10)64034-5 – ident: e_1_2_7_10_2 doi: 10.1016/S0140-6736(02)07499-8 – ident: e_1_2_7_37_2 doi: 10.1074/jbc.M008072200 – ident: e_1_2_7_12_2 doi: 10.1023/A:1020583306627 – ident: e_1_2_7_9_2 doi: 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S – ident: e_1_2_7_32_2 doi: 10.1097/01.LAB.0000048719.53282.00 – ident: e_1_2_7_6_2 doi: 10.1074/jbc.270.45.27348 – ident: e_1_2_7_4_2 doi: 10.1189/jlb.72.1.9 – ident: e_1_2_7_19_2 doi: 10.1080/003655201750313397 – ident: e_1_2_7_25_2 doi: 10.1136/gut.38.2.216 – ident: e_1_2_7_2_2 doi: 10.1056/NEJM199802123380706 – ident: e_1_2_7_30_2 doi: 10.1016/S0002-9440(10)62527-8 – ident: e_1_2_7_38_2 doi: 10.1084/jem.167.2.570 – ident: e_1_2_7_26_2 doi: 10.1080/003655201750153377 – ident: e_1_2_7_36_2 doi: 10.1038/35079114 – ident: e_1_2_7_1_2 doi: 10.1182/blood.V90.3.909 – ident: e_1_2_7_42_2 doi: 10.1136/gut.47.3.404 – ident: e_1_2_7_22_2 doi: 10.1007/PL00000223 – ident: e_1_2_7_11_2 doi: 10.1016/S0140-6736(02)07284-7 – ident: e_1_2_7_13_2 doi: 10.1056/NEJMra020831 – volume: 92 start-page: 283 year: 1997 ident: e_1_2_7_28_2 article-title: Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histologial assessment and Tc‐99 m‐HMPAO labeled leukocyte scan. publication-title: Am. J. Gastroenterol. – ident: e_1_2_7_33_2 doi: 10.1136/gut.38.1.90 – volume: 144 start-page: 997 year: 1994 ident: e_1_2_7_20_2 article-title: Expression of interleukin‐8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. publication-title: Am. J. Pathol. – ident: e_1_2_7_39_2 doi: 10.1002/1521-4141(200112)31:12<3755::AID-IMMU3755>3.0.CO;2-O |
SSID | ssj0009659 ssj0013055 |
Score | 2.0374753 |
Snippet | Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1992 |
SubjectTerms | Angiogenesis Chemokine CXCL6 Chemokines, CXC - biosynthesis Chemokines, CXC - metabolism Crohn Disease - blood Crohn Disease - metabolism Crohn Disease - pathology Crohn's disease Down-Regulation Endothelial Cells - metabolism Enzyme-Linked Immunosorbent Assay Granulocyte chemotactic protein‐2 Humans Immunohistochemistry Inflammation - blood Inflammation - metabolism Inflammatory bowel diseases Intercellular Signaling Peptides and Proteins - biosynthesis Intercellular Signaling Peptides and Proteins - metabolism Interleukin-8 - biosynthesis Interleukin-8 - metabolism Interleukin‐8 Intestines - metabolism Intestines - pathology Leukocytes - metabolism Receptors, Interleukin-8A - biosynthesis Receptors, Interleukin-8A - metabolism |
Title | CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Feji.200324807 https://www.ncbi.nlm.nih.gov/pubmed/15214047 https://www.proquest.com/docview/19439504 https://www.proquest.com/docview/66646611 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQJRAXHuW1PH1AcCHdPBzH4YailrZqEaqotLfgcWxYdptUm6xgOfET-Fv8DX4JYzu7qwUVCRHlEske2_J4_Dkz_oaQp6ICyLWCgGdGBQxMFuQKwiBTObN-oYg7surjN3z_lB2O0lGf59TehfH8EKsfbnZlOHttF7iEdrgmDdWfxo7OM7aXotEG23gtC4pO1vRRlizPW2IWxLkIe45NrD_cqL25J_0BNDdxq9t49q6T98su-3iTyc68gx319Tc2x_8Y0w1yrQel9JXXopvkkq63yWWfpnKxTa4c9w74W-RHMSpOop_fvsPYXYehOOdnzcTGztNxja9BDTtznnsKzWc9pb0HqH1JKzzwY82Z_mBThumKHhzhpxiiyCNBzz31LKoJhQWd6vmkUYvOiy1mzcf6ebuURWVd0dYl8EFbTV8Xb1FO7ORwqr_0ob31ukPYlqXFQGtmh9k5XbtNTvd23xX7QZ8NIlAsYVnAEplHsbTnG2Z4ajLIE6NSAQJBZpRryU2upIxNCIZJngPXgFttBkYJoQ0kd8hW3dT6HqFSykxmokrwYVHEgQuuDR5ck1SISrABebHUh1L1VOk2Y8e09CTPcYkTVa4makCerYqfe46Qiwo-WSpXiavYumZkrZt5W0Y5AsM0ZBeXwGMmQywVDchdr5XrphCBsZCh9NDp1t_7UO4eHqw-7v97lQfkqg9eshHLD8lWN5vrR4jLOnjsFt8vt6k0qw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxELagiMeFRykQXvUBwYVt9uH12tzQqiUpSYWqVsptZXttCEl3qzwE4cRP4G_xN_gljO1NQkBFQqz2Yske2_KMPeMZf4PQM1ZKybWSAc2MCog0WcCVDINMcWL9QhF1YNX9I9o5JYeDdPDLK36PD7G6cLOS4fZrK-D2Qrq9Rg3VH4cOzzO2r6Ivoys2q7czqo7XAFIWLs_vxSSIOQsblE0g0N5ovnkq_aFqbmqu7ug5uIXEctA-4mS0N5_JPfXlNzzH_5nVbXSz0Uvxa89Id9AlXW2jqz5T5WIbXes3Pvi76Hs-yI-jH1-_yaF7EYNh2c_qkQ2fx8MKfgNMduac91jWn_QYN06g6Stcgs0PLSf6vc0apkvc7UGRtYFkj-Fzjz4LnILlAo_1fFSrxcyTzSf1h-rFdEkLi6rEU5fDB7Zr_CZ_B3RiR4di_bmJ7q3WA4K-LDIGbGh2mjPHbjvo9GD_JO8ETUKIQJGEZAFJBI9iYU0cYmhqMskTo1ImGeiZEdeCGq6EiE0oDRGUS6olnLaZNIoxbWRyD21VdaUfICyEyETGygQ-EkVUUka1Ads1SRkrGWmhl0uGKFSDlm6TdowLj_McF7BQxWqhWuj5qvq5hwm5qOLukrsKEGTrnRGVrufTIuKgG6YhubgGWJoE1Kmohe57tlx3BUoYCQlQDx1z_X0Mxf5hd1V4-O9NdtH1zkm_V_S6R28foRs-lskGMD9GW7PJXD8BNW0mnzpJ_AnbCjjG |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZgiIkXLuNWbvMDghey5uI4Dm8oW1lHN00Tk_qW2Y7NunZJ1aaC8sRP4G_xN_glHNtpq4KGhIjyEsk-tuXP9jk5x99B6CUrhEiVFB5NtPSI0ImXSuF7iUyJ8QsF1JJVHx7R_VNy0I_7TZ5TcxfG8UMsf7iZlWH3a7PAx4Vur0hD1cXA0nmG5lL0dXSDUJ8ZWO-erPijDFue24qJF6bMb0g2QUB7rfr6ofSHprmuuNqTp3MHnS367AJOhjuzWuzIr7_ROf7HoO6i241Wit85GN1D11S5hW66PJXzLbR52Hjg76MfWT87CX5--y4G9j4Mhkm_rIYmeB4PSng1QOzSuu6xqD6rEW5cQNO3uACLH2pO1CeTM0wVuNuDT9YGkT2Gx457FnCCxRyP1GxYyXntxGaT6rx8PV3Iwrws8NRm8IHNGr_PjkFOaOVQrL40sb3lqkPQluHFgO3MDLO2YHuATjt7H7N9r0kH4UkSkcQjEU-DkBsDh2ga60SkkZYxEwy0zCBVnOpUch5qX2jCaSqoEnDWJkJLxpQW0UO0UValeoww5zzhCSsieEgQUEEZVRos1yhmrGCkhd4s8JDLhivdpOwY5Y7lOcxhovLlRLXQq2XxsSMJuarg9gJcOSxj45vhpapm0zxIQTOMfXJ1CbAzCShTQQs9cqhcNQUqGPEJSPcttv7eh3zvoLv8ePLvVbbR5vFuJ-91jz48RbdcIJOJXn6GNurJTD0HHa0WL-w6_AUqJDd- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CXCR1%E2%80%90binding+chemokines+in+inflammatory+bowel+diseases%3A+down%E2%80%90regulated+IL%E2%80%908%2FCXCL8+production+by+leukocytes+in+Crohn%27s+disease+and+selective+GCP%E2%80%902%2FCXCL6+expression+in+inflamed+intestinal+tissue&rft.jtitle=European+journal+of+immunology&rft.au=Gijsbers%2C+Klara&rft.au=Van+Assche%2C+Gert&rft.au=Joossens%2C+Sofie&rft.au=Struyf%2C+Sofie&rft.date=2004-07-01&rft.issn=0014-2980&rft.eissn=1521-4141&rft.volume=34&rft.issue=7&rft.spage=1992&rft.epage=2000&rft_id=info:doi/10.1002%2Feji.200324807&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_eji_200324807 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2980&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2980&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2980&client=summon |